Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-15
2007-05-15
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S277400
Reexamination Certificate
active
10517446
ABSTRACT:
The compound of the formula (I):wherein W is a group of the following formula (VIII) binding to any possible position on the Q:Q is, together with W, a group of the formula: —C(W)═C(R3A)—N(R3)—, etc.; R3Ais H or optionally substituted lower alkyl; R4, R5, R6, and R7are independently H or optionally substituted lower alkyl; R1is optionally substituted lower alkyl, etc.; R2is H, etc.; R3is H, etc.; Ar is phenyl, etc., or a pharmaceutically acceptable salt thereof, where these compounds exhibiting β3-adrenoceptor-stimulating activity and being useful as a medicament for treatment of obesity, etc.
REFERENCES:
patent: 2908691 (1959-10-01), Robinson
patent: 3705233 (1972-12-01), Lunts
patent: 4378361 (1983-03-01), Schromm et al.
patent: 4540581 (1985-09-01), Nair
patent: 4581367 (1986-04-01), Schromm et al.
patent: 4647563 (1987-03-01), Schromm et al.
patent: 4987133 (1991-01-01), Kurmeier et al.
patent: 4990509 (1991-02-01), Arrowsmith et al.
patent: 5030640 (1991-07-01), Fisher et al.
patent: 5114952 (1992-05-01), Arrowsmith et al.
patent: 5817689 (1998-10-01), Kato et al.
patent: 6310050 (2001-10-01), Advenier et al.
patent: 6458824 (2002-10-01), Iwata et al.
patent: 8-165276 (1996-06-01), None
patent: 11-255743 (1999-09-01), None
patent: WO-96/16038 (1996-05-01), None
patent: WO-01/17513 (2001-03-01), None
patent: WO-02/64133 (2002-08-01), None
patent: WO-02/74306 (2002-09-01), None
M.V. Sennitt et al., The Journal of Pharmacology and Experimental Therapeutics, vol. 285, No. 3, pp. 1084-1095, 1998.
J.E. Clifton et al., J. Med. Chem, vol. 25, No. 6, pp. 670-679, 1982.
Tetrahedron Lett., (2001), 42(43), p. 7671-4.
Chemical Abstracts, vol. 135, abs. No. 344399, RN=371752-47-5 (2003).
Chemical Abstracts, vol. 132, abs. No. 152006, RN=258267-67-3 (2003).
J. Org. Chem., (1991), 56(14), p. 4403-7.
J. Med. Chem., (1980), 23(11), p. 1268-9.
Can. Med. Chem., (1976), 54(8), p. 1262-77.
Chemical Abstracts, vol. 109, abs. No. 128763.
J. Med. Chem., (1982), 26(6), p. 670-9.
Hirota Kotaro
Noguchi Tsuyoshi
Sawada Nobuyuki
Ueno Yoshihide
Umezome Takashi
Birch & Stewart Kolasch & Birch, LLP
Dainippon Sumitomo Pharma Co. ,Ltd.
Freistein Andrew B.
McKane Joseph K.
LandOfFree
Indole, indazole, and benzazole derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole, indazole, and benzazole derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole, indazole, and benzazole derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3792374